-+ 0.00%
-+ 0.00%
-+ 0.00%

Biogen Stock Rises Even as Multiple Sclerosis Revenue Tumbles. It Sees Continued Declines in the Portfolio.

Barron‘s·02/06/2026 12:35:00

Please log in to view news